Expression of the IL-12 receptor β1 and β2 subunits in human tuberculosis

Journal of Immunology

Volumn 162, Issue 4, 1999, Pages 2441-2447

  Zhang, Ming ^a   Gong, Jianhua ^a   Presky, David H ^c   Xue, Wanfen ^d   Barnes, Peter F ^a,b  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b Baylor UT Houston Center for AIDS Research   (United States)

^c Nanjing Medical University ^*  (United States)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 12 RECEPTOR; MESSENGER RNA; RECEPTOR SUBUNIT; RECOMBINANT INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUBERCULIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TISSUE SPECIFICITY; TUBERCULOSIS;

CELLS, CULTURED; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS;

EID: 0033558107     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Dolin, P. J., M. C. Raviglione, and A. Kochi. 1993. Estimate of future global tuberculosis morbidity and mortality. Morbid. Mortal. Wkly. Rep. 42:961.
2. Sanchez, F. O., J. I. Rodriguez, G. Agudelo, and L. F. Garcia. 1994. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect. Immun. 62:5673.
3. Zhang, M., Y. Lin, D. V. Iyer, J. Gong, J. S. Abrams, and P. F. Barnes. 1995. T cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63:3231.
4. Rossol, S., G. Marinos, P. Carucci, M. V. Singer, R. Williams, and N. V. Naoumov. 1997. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J. Clin. Invest. 99:3025.
5. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J. Immunol. 155:785.
6. Magee, D. M., and R. A. Cox. 1995. Roles of γ Interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect. Immun. 63: 3514.
7. Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immuno-regulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675.
8. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
9. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825.
10. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817.
11. Jones, D., M. M. Elloso, L. Showe, D. Williams, G. Trincheri, and P. Scott. 1998. Differential regulation of the interleukin-12 receptor during the innate immune response Leishmania major. Infect. Immun. 66:3818.
12. Wu, C.-Y., R. Warrier, D. M. Carvajal, A. O. Chua, L. J. Minetti, R. Chizzonite, P. K. A. Mongini, A. S. Stern, U. Gubler, D. H. Presky, and M. K. Gately. 1996. Biological function and distribution of human interleukin-12 receptor β chain. Eur. J. Immunol. 26:345.
13. Presky, D. H., H. Yang, L. J. Minetti, A. O. Chua, N. Nabavi, C. Y. Wu, M. K. Gately, and U. Gubler. 1996. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 93:14002.
14. Reik, L. M., S. L. Maines, D. E. Ryan, W. Levin, S. Bandiera, and P. E. Thomas. 1987. A simple non-chromatographic purification procedure for monoclonal antibodies: isolation of monoclonal antibodies against cytochrome P450 isozymes. J. Immunol. Methods 100:123.
15. Barnes, P. F., D. Chatterjee, J. S. Abrams, S. Lu, E. Wang, M. Yamamura, P. J. Brennan, and R. L. Modlin. 1992. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan: relationship to chemical structure. J. Immunol. 149:541.
16. Law, K. F., J. Jagirdar, M. D. Weiden, M. Bodkin, and W. N. Rom. 1996. Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am. J. Respir. Crit. Care Med. 153:1377.
17. Lin, Y., M. Zhang, F. M. Hofman, J. Gong, and P. F. Barnes. 1996. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect. Immun. 64: 1351.
18. Barnes, P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamamura, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482.
19. Dahl, K. E., H. Shiratsuchi, B. D. Hamilton, J. J. Ellner, and Z. Toossi. 1996. Selective induction of transforming growth factor β in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect. Immun 64:399.
20. Toossi, Z., T. Young, L. E. Averill, B. D. Hamilton, H. Shiratsuchi, and J. J. Ellner. 1995. Induction of transforming growth factor β1 by purified protein derivative of Mycobacterium tuberculosis. Infect. Immun. 63:224.
21. Sieling, P. A., J. S. Abrams, M Yamamura, P. Salgame, B. R. Bloom, T. H. Rea, and R. L. Modlin. 1993. Immunosuppressive roles for interleukin-10 and interleukin-4 in human infection: in vitro modulation of T cell responses in leprosy. J. Immunol. 150:5501.
22. Hirsch, C. S., R. Hussain, Z. Toossi, G. Dawood, F. Shahid, and J. J. Ellner. 1996. Cross-modulation by transforming growth factor β in human tuberculosis: suppression of antigen-driven blastogenesis and interferon γ production. Proc. Natl. Acad. Sci. USA 93:3193.
23. Hirsch, C. S., J. J. Ellner, R. Blinkhorn, and Z. Toossi. 1997. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor β. Proc. Natl. Acad. Sci. USA 94:3926.
24. Gong, J., M. Zhang, R. L. Modlin, P. S. Linsley, D. Iyer, Y. Lin, and P. F. Barnes. 1996. Interleukin-10 down-regulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect. Immun. 64:913.
25. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
26. Skeen, M. J., M. A. Miller, T. M. Shinnick, and H. K. Ziegler. 1996. Regulation of murine macrophage IL-12 production. J. Immunol. 156:1196.
27. Yamamura, M., K. Uyemura, R. J. Deans, K. Weinberg, T. H. Rea, B. R. Bloom, and R. L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277.
28. Pirmez, C., M. Yamamura, K. Uyemura, M. Paes-Oliveira, F. Conceiçao-Silva, and R. L. Modlin. 1993. Cytokine patterns in pathogenesis of human leishmaniasis. J. Clin. Invest. 91:1390.
29. Ghalib, H. W., M. R. Piuvezam, Y. A. W. Skeiky, M. Siddig, F. A. Hashim, A. M. El-Hassan, D. M. Russo, and S. G. Reed. 1993. Interleukin-10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92:324.
30. Holaday, B. J., M. M. de Lima Pompeu, S. Jeronimo, M. J. Texeira, A. de Queiroz Sousa, A. W. Vasconcelos, R. D. Pearson, J. S. Abrams, and R. M. Locksley. 1993. Potential role for inlerleukin-10 in the immunosuppression associated with kala azar. J. Clin. Invest. 92:2626.
31. + T cells. Annu. Rev. Immunol. 12:635.
32. Miller, M. A., M. J. Skeen, and H. K. Ziegler. 1995. Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J. Immunol. 155:4817.
33. Pie, S., P. Truffa-Bachi, M. Pla, and C. Nauciel. 1997. Th1 response in Salmonella typhimurium-infected mice with a high or low rate of bacterial clearance. Infect. Immun. 65:4509.
34. Scott, P. 1993. IL-12: Initiation cytokine for cell-mediated immunity. Science 260:496.
35. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Th1 cells. Immunol. Today 14:335.
36. Frutch, D. M., and S. M. Holland. 1996. Defective monocyte costimulation for IFN-γ production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. J. Immunol. 157:411.
37. Altare, F., A. Durandy, D. Lammas, J.-F. Emile, S. Lamhamedi, F. Le Deist, P. Drysdale, E. Jouanguy, R. Doffinger, F. Bernaudin, et al. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432.
38. De Jong, R., F. Altare, I.-A. Haagen, D. G. Elferink, T. de Boer, P. J. C. van Breda Vriseman, P. J. Kabel, J. M. T. Draaisma, J. T. van Dissel, F. P. Kroon, J.-L. Casanova, and T. H. M. Ottenhoff. 1998. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435.
39. Zhang, M., M. K. Gately, E. Wang, J. Gong, S. F. Wolf, S. Lu, R. L. Modlin, and P. F. Barnes. 1994. Interleukin-12 at the site of disease in tuberculosis. J. Clin. Invest. 93:1733.
40. Gorham, J. D., M. L. Guler, D. Fonogliao, U. Gubler, and K. M. Murphy. 1998. Low dose TGF-β attenuates IL-12 responsiveness in murine Th1 cells. J. Immunol. 161:1664.
41. Bright, J. J., and S. Sriram. 1998. TGF-β inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J. Immunol. 161:1772.
42. Toossi, Z., P. Gogate, H. Shiratsuchi, T. Young, and J. J. Ellner. 1995. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J. Immunol. 154:465.